# HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
> **ANDA087085** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN
## Drug
- **FDA Application Number:** ANDA087085
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087085)
---
*AI Analytics · CC0 1.0*